David Kotler

David Kotler

Dechert LLP

Contact  |  View Bio  |  RSS

Latest Publications


U.S. Fund Litigation Update: Where We are Now and Where We Could be Headed

Five years removed from the credit crisis and “great recession” of 2008, the U.S. fund industry still faces substantial litigation risk, both in terms of ongoing cases that challenge the core of the advisory/sub-advisory...more

3/28/2014 - Investment Companies Investment Company Act of 1940 Investment Funds SEC Securities Act of 1933 Securities Exchange Act

Dechert Survey of Securities Fraud Class Actions Brought Against U.S. Life Sciences Companies

Publicly Traded Life Sciences Companies in the United States Remain an Increasingly Popular Target of Securities Fraud Class Action Lawsuits: The past year was particularly noteworthy with respect to the absolute and...more

3/20/2013 - Amgen Inc. v Connecticut Retirement Plans Class Action FDA Fraud Life Sciences Marketing Off-Label Promotion Pharmaceutical Securities Fraud

2 Results
View per page
Page: of 1